Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials

被引:116
|
作者
Vetvicka, Vaclav [1 ]
Vannucci, Luca [2 ]
Sima, Petr [2 ]
Richter, Josef [3 ]
机构
[1] Univ Louisville, Dept Pathol & Lab Med, Louisville, KY 40292 USA
[2] Inst Microbiol, Dept Immunol, Prague 14220, Czech Republic
[3] Zdravotni Ustav Sidlem Usti Nad Labem, Usti Nad Labem 40001, Czech Republic
来源
MOLECULES | 2019年 / 24卷 / 07期
关键词
glucan; drug; immunity; food; supplement; infection; mushrooms; PLEUROTUS-OSTREATUS; INNATE IMMUNITY; RESPIRATORY-INFECTIONS; OAT-BRAN; RESISTANCE; RESPONSES; MICE; NUTRITION; CYTOKINES; ANTITUMOR;
D O I
10.3390/molecules24071251
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucans are part of a group of biologically active natural molecules and are steadily gaining strong attention not only as an important food supplement, but also as an immunostimulant and potential drug. This paper represents an up-to-date review of glucans (beta-1,3-glucans) and their role in various immune reactions and the treatment of cancer. With more than 80 clinical trials evaluating their biological effects, the question is not if glucans will move from food supplement to widely accepted drug, but how soon.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Laboratory guidelines and clinical trials - A focus on the role of the laboratory
    Sacks, DB
    CLINICA CHIMICA ACTA, 2005, 355 : S41 - S41
  • [32] Analysis of clinical drug trials in children compared to clinical drug trials in adults, in Argentina
    Traversi, Laura
    Bolanos, Ricardo
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (01): : 34 - 40
  • [33] From laboratory to human clinical trials: A successful investigational new drug application for detecting early stage cardiovascular disease
    McGrath, Alaina
    Pressly, Eric
    Liu, Yongjian
    Laforest, Richard
    Luehmann, Hannah
    Schwarz, Sally
    Sultan, Deborah
    Gropler, Robert
    Woodard, Pamela
    Hawker, Craig
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [34] beta-glucan affects mucosal immunity in children with chronic respiratory problems under physical stress: clinical trials
    Richter, Josef
    Svozil, Vladimir
    Kral, Vlastimil
    Dobiasova, Lucie Rajnohova
    Vetvicka, Vaclav
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (04)
  • [35] Clinical trials of yeast-derived beta-(1,3) glucan in children: effects on innate immunity
    Richter, Josef
    Svozil, Vladimir
    Kral, Vlastimil
    Dobiasova, Lucie Rajnohova
    Stiborova, Ivana
    Vetvicka, Vaclav
    ANNALS OF TRANSLATIONAL MEDICINE, 2014, 2 (02)
  • [36] LABORATORY AND CLINICAL-TRIALS WITH CEFOTAXIME
    NAKAGAWA, K
    WATANABE, K
    FUKUI, K
    KOYAMA, M
    NAKAZAWA, K
    YOKOZAWA, M
    CHEMOTHERAPY-TOKYO, 1980, 28 : 243 - 252
  • [37] BETA GLUCAN AS SUPPLEMENT TREATMENT DECREASES OXIDATIVE STRESS IN CHILDREN WITH ALLERGIC RHINITIS TREATED WITH CORTICOSTEROIDS
    Zendelovska, Dragica
    Petrusevska, Marija
    Arnaudova, Ivana
    Atanasovska, Emilija
    FREE RADICAL BIOLOGY AND MEDICINE, 2023, 201 : 37 - 37
  • [38] Drug development: Clinical trials
    Jaffe, S
    SCIENTIST, 2003, 17 (10): : 12 - 12
  • [39] Fate of Clinical Drug Trials
    van den Bogert, Cornelis A.
    Souverein, Patrick C.
    Brekelmans, Cecile T. M.
    Janssen, Susan W. J.
    Koeter, Gerard
    Leufkens, Hubert G. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 216 - 216
  • [40] Clinical Trials and Drug Development
    Mahipal, Amit
    CANCER CONTROL, 2014, 21 (03) : 188 - 189